Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-20-006882)

Filing Details

Accession Number:: 0001213900-20-006882
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-19 16:18:18
Reporting Period:: 2020-03-18

Accepted Time:: 2020-03-19 16:18:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777330	Phoebe Mounts	C/O Cormedix Inc. 400 Connell Drive, Suite 5000 Berkeley Heights NJ 07922	General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-18	3,250	$3.05	4,675	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy Common Stock)	$5.63		2030-02-25	24,764	24,764	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$7.92		2029-05-01	70,000	70,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2030-02-25	24,764	24,764	Direct
2029-05-01	70,000	70,000	Direct

Footnotes

These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
The options vest as follows: 42,000 vest in equal fourths on May 1 of each of 2020, 2021, 2022 and 2023 and 28,000 vest upon the achievement of designated milestones.